Intervention Review

Loxapine for schizophrenia

  1. Abhijit Chakrabarti1,*,
  2. Anne-Marie Bagnall2,
  3. Pierre Chue3,
  4. Mark Fenton4,
  5. Vikram Palaniswamy5,
  6. Winson Wong6,
  7. Jun Xia7

Editorial Group: Cochrane Schizophrenia Group

Published Online: 17 OCT 2007

Assessed as up-to-date: 6 AUG 2007

DOI: 10.1002/14651858.CD001943.pub2

How to Cite

Chakrabarti A, Bagnall AM, Chue P, Fenton M, Palaniswamy V, Wong W, Xia J. Loxapine for schizophrenia. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD001943. DOI: 10.1002/14651858.CD001943.pub2.

Author Information

  1. 1

    Becklin Centre, Leeds, UK

  2. 2

    Leeds Metropolitan University, Faculty of Health, Leeds, UK

  3. 3

    University of Alberta, Department of Psychiatry, Edmonton, Alberta, Canada

  4. 4

    National Institute for Health and Clinical Excellence, Database of Uncertainties about the Effects of Treatments (DUETs), Manchester, UK

  5. 5

    Leeds Mental Health NHS Teaching Trust, Psychiatry, Leeds, West Yorkshire, UK

  6. 6

    Yorkshire and Humber Postgraduate Deanery, Sheffield, UK

  7. 7

    University of Nottingham, Cochrane Schizophrenia Group, Nottingham, UK

*Abhijit Chakrabarti, Becklin Centre, Alma Road, St James' University Hospital, Leeds, LS9 7BE, UK. abhijitchakrabarti@yahoo.co.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 17 OCT 2007

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Glenn Currier, Patrick Walsh, Safety and Efficacy Review of Inhaled Loxapine for Treatment of Agitation, Clinical Schizophrenia & Related Psychoses, 2013, 7, 1, 25

    CrossRef

  2. 2
    Donna Gillies, Stephanie Sampson, Alison Beck, John Rathbone, Donna Gillies, Cochrane Database of Systematic Reviews, 2013,

    CrossRef

  3. 3
    Joseph Kwentus, Robert A Riesenberg, Morteza Marandi, Raymond A Manning, Michael H Allen, Robert S Fishman, Daniel A Spyker, John H Kehne, James V Cassella, Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine, Bipolar Disorders, 2012, 14, 1
  4. 4
    Donna Gillies, Stephanie Sampson, Alison Beck, John Rathbone, Benzodiazepines for psychosis-induced aggression or agitation, The Cochrane Library,
  5. 5
    Uzair Ahmed, Hannah Jones, Clive E Adams, Chlorpromazine for psychosis induced aggression or agitation, The Cochrane Library,
  6. 6
    Rohini Vangala, Uzair Ahmed, Rais Ahmed, Loxapine inhaler for psychosis-induced aggression or agitation, The Cochrane Library,
  7. 7
    Uzair Ahmed, Faiz Rehman, Hannah Jones, Clive E Adams, Risperidone for psychosis induced aggression or agitation, The Cochrane Library,